Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults
- 27 February 2004
- Vol. 22 (23-24) , 3182-3186
- https://doi.org/10.1016/j.vaccine.2004.01.053
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Sendai Virus, a Murine Parainfluenza Virus Type 1, Replicates to a Level Similar to Human PIV1 in the Upper and Lower Respiratory Tract of African Green Monkeys and ChimpanzeesVirology, 2002
- Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United StatesThe Pediatric Infectious Disease Journal, 2001
- Strategies of immunization against mucosal infectionsVaccine, 2000
- Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type oneVaccine, 1997
- Age-Related Development of Human Memory T-Helper and B-Cell Responses toward Parainfluenza Virus Type-1Virology, 1994
- The nucleoproteins of human parainfluenza virus type 1 and Sendai virus share amino acid sequences and antigenic and structural determinantsJournal of General Virology, 1991
- The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivityVirology, 1990
- Sendai VirusPublished by Elsevier ,1978
- RESPIRATORY VIRUS IMMUNIZATIONAmerican Journal of Epidemiology, 1969
- Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccinesJAMA, 1967